retatrutide clinical trials phase 2 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New 3 results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of retatrutide availability clinical trial Triple

That due diligence matters more than usual right now, because compounded GLP-1 medications are prescription drugs with real metabolic effects and real risks, and the telehealth platforms offering them operate in a regulatory environment that has shifted significantly over the past year

Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding

doi:10.2337/db07-1824 Yang X, Qiang Q, Li N, Feng P, Wei W, Hlscher C

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation